Concepedia

Moez Nayyar

MN

6

Publications

1.8K

Citations

6

H-Index

2005

Active since

Affiliations

University of Oxford(Current)

University of Nottingham

Nottingham University Hospitals NHS Trust

University College London

University of Bristol

Moez Nayyar is an author at University of Oxford specializing in medicine, covid-19, and clinical trials.

Top concepts

Publications per year

2005–2024

6

Publications

6

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

, , +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

Speeding and maxillofacial injuries: Impact of the introduction of penalty points for speeding offences

O.T. Hussain, Moez Nayyar, F.A. Brady et al. · British Journal of Oral and Maxillofacial Surgery · 2005 · 40 citations

, , +7

Rows per page

1–5 of 6